# Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits

> **NCT04024007** · — · UNKNOWN · sponsor: **Dr David DE BELS** · enrollment: 100 (estimated)

## Conditions studied

- Dialysis

## Interventions

- **DIAGNOSTIC_TEST:** Citrate dosage

## Key facts

- **NCT ID:** NCT04024007
- **Lead sponsor:** Dr David DE BELS
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2019-09-01
- **Primary completion:** 2023-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04024007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04024007, "Determination of Citrate Clearance Used in Regional Anticoagulation of Continuous Venous Hemofiltration Circuits". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04024007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*